Variant report
Variant | esv12218 |
---|---|
Chromosome Location | chr9:15020755-15022389 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34196279 | chr9:15020768-15020769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2382510 | chr9:15020769-15020770 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs567519731 | chr9:15020828-15020829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538272765 | chr9:15020859-15020860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17223865 | chr9:15020861-15020862 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs574846992 | chr9:15020862-15020863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571760300 | chr9:15020875-15020876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12343244 | chr9:15020913-15020914 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs554366806 | chr9:15020919-15020920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572680506 | chr9:15020978-15020979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12344181 | chr9:15021010-15021011 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs555258500 | chr9:15021011-15021012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573539570 | chr9:15021024-15021025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7848992 | chr9:15021048-15021049 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs562436929 | chr9:15021054-15021055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs59555304 | chr9:15021092-15021093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs544710399 | chr9:15021097-15021098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373481489 | chr9:15021109-15021110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10511604 | chr9:15021118-15021119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs567896334 | chr9:15021121-15021122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12353220 | chr9:15021184-15021185 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs561264199 | chr9:15021201-15021202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376005571 | chr9:15021203-15021204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531606403 | chr9:15021206-15021207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555338081 | chr9:15021213-15021214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149357614 | chr9:15021224-15021225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571560510 | chr9:15021226-15021227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539087256 | chr9:15021236-15021237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113035343 | chr9:15021250-15021251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188792974 | chr9:15021295-15021296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12353266 | chr9:15021297-15021298 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs112542779 | chr9:15021301-15021302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554941117 | chr9:15021316-15021317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192831026 | chr9:15021361-15021362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558921197 | chr9:15021407-15021408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537430445 | chr9:15021440-15021441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12353337 | chr9:15021471-15021472 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs10511605 | chr9:15021481-15021482 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs565471426 | chr9:15021515-15021516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544671842 | chr9:15021554-15021555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs78285948 | chr9:15021580-15021581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13283582 | chr9:15021594-15021595 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs13302236 | chr9:15021608-15021609 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs13283720 | chr9:15021653-15021654 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs73421756 | chr9:15021664-15021665 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs370201578 | chr9:15021669-15021670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13283735 | chr9:15021682-15021683 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs13302511 | chr9:15021707-15021708 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs184252098 | chr9:15021715-15021716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs13302526 | chr9:15021734-15021735 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:15020200-15021200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:15021200-15021800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |